5D-QSAR: The key for simulating induced fit?

Journal of Medicinal Chemistry

Volumn 45, Issue 11, 2002, Pages 2139-2149

  Vedani, Angelo ^a   Dobler, Max ^a  

^a Biographics Laboratory 3R   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIPHENYL DERIVATIVE; DIBENZODIOXIN DERIVATIVE; DIBENZOFURAN DERIVATIVE; NEUROKININ 1 RECEPTOR; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; CONFORMATION; MOLECULAR MODEL; PROTON TRANSPORT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR BINDING;

LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, NEUROKININ-1; THERMODYNAMICS;

EID: 0037161586     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm011005p     Document Type: Article

References (52)

1. QSAR and 3-D QSAR in drug design. 1. Methodology
2. QSAR and 3-D QSAR in drug design. 2. Applications and problems
3. Current state, scope, and limitations
4. Pseudoreceptors
5. Three-dimensional receptor modeling using distance geometry and Voronoi polyhedra
6. 3 hybridized O atoms and its relevance to ligandmacromolecule interactions
7. Lone-pair directionality in H-bond potential functions for molecular mechanics calculations
8. Hydrogen bonding in globular proteins
9. Catalyst pharmacophore models and their utility as queries for searching 3D databases
10. Construction of 3D-QSAR models using 4D-QSAR analysis formalism
11. Three-dimensional quantitative structureactivity relationships from molecular similarity matrixes and genetic neural networks
12. Multiple conformation and protonation-state representation in 4D-QSAR: The neurokinin-1 receptor system
13. Multidimensional QSAR in drug research: Predicting binding affinities, toxicity, and pharmacokinetic parameters
14. Multi-conformational ligand representation in 4D-QSAR: Reducing the bias associated with ligand alignment
15. Induced fit - The key for understanding LSD activity. A 4D-QSAR study on the 5-HT2A receptor system
16. Quasi-atomistic receptor surface models: A bridge between 3-D QSAR and receptor modeling
17. PNP inhibitors
18. Effect of the 7-amino substituent on the inhibitory potency of mechanism-based isocoumarin inhibitors for porcine pancreatic and human neutrophil elastases: A 1.85-Å X-ray structure of the complex between porcine pancreatic elastase and 7-[(N-tosylphenylalanyl)amino]-4-chloro3-methoxyisocoumarin
19. Receptor surface models. 1. Definition and construction
20. Genetically evolved receptor models: A computational approach to construction of receptor models
21. Receptor surface models. 2. Application to quantitative structure -activity studies
22. Pharmacophore modeling and threedimensional database searching for drug design using "Catalyst"
23. Gridindpendent descriptors (GRIND): A novel class of alignmentindependent three-dimensional descriptors
24. Selforganizing molecular field analysis: A tool for structure-activity studies
25. Genetic function approximation to generate a family of QSAR equations using genetic algorithms
26. Molecular mechanics simulation of protein-ligand interactions: Binding of thyroid analogues to prealbumin
27. Semianalytical treatment of solvation for molecular mechanics and dynamics
28. The cost of conformational order: Entropy changes in molecular associations
29. Pseudoreceptor modeling: The construction of three-dimensional receptor surrogates
30. A new force field for modeling metalloproteins
31. 3D molecular lipophilicity potential profiles: A new tool in molecular modeling
32. Atomic physicochemical parameters for three-dimensional structure-directed structure-activity relationships I: Partition coefficients as a measure of hydrophobicity
33. Receptors and antagonists for substance P and related peptides
34. The tachykinin NK-1 receptor. Part I: Ligands and mechanisms of cellular activation
35. The dual nature of the tachykinin NK-1 receptor
36. Derivation of a three-dimensional pharmacophore model of substance P antagonists bound to the NK-1 receptor
37. N-Heteroaryl-2-phenyl-3-(benzyloxy)piperidines: A novel class of potent orally active human NK-1 antagonists
38. Estimating relative potency for receptormediated toxicity: Reevaluating the toxicity-equivalence factor (TEF) model
39. Cellular and molecular biology of Aryl hydrocarbon (Ah) receptor-mediated gene expression
40. The Ah receptor: Mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds
41. Environmental concentrations and ecotoxicological effects of PCDDs, PCDFs and related compounds
42. Mechanistic aspects of dioxin action
43. Genetische Algorithmen im 3D- QSAR: Verwendung multipler Wirkstofforientierungen zur verbesserten Voraussage der Toxizität
44. Internet laboratory for predicting harmful effects triggered by drugs and chemicals
45. Multidimensional QSAR: Moving from three-to five-dimensional concepts